Close Menu

NEW YORK (GenomeWeb) – Biocept today announced an agreement to participate in MultiPlan's national primary preferred provider organization and complementary network.

Under the terms of the agreement, patients in MultiPlan's networks will have access to Biocept's liquid biopsy diagnostic services, effective August 1. MultiPlan is a national healthcare organization under contract with almost 900,000 providers, Biocept said in a statement, adding about 68 million consumers access the healthcare cost management firm's networks.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.